These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 31713604)

  • 1. Transactivation of SOX5 by Brachyury promotes breast cancer bone metastasis.
    Chen M; Zou S; He C; Zhou J; Li S; Shen M; Cheng R; Wang D; Zou T; Yan X; Huang Y; Shen J
    Carcinogenesis; 2020 Jul; 41(5):551-560. PubMed ID: 31713604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sox5 induces epithelial to mesenchymal transition by transactivation of Twist1.
    Pei XH; Lv XQ; Li HX
    Biochem Biophys Res Commun; 2014 Mar; 446(1):322-7. PubMed ID: 24607904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FOX-A1 contributes to acquisition of chemoresistance in human lung adenocarcinoma via transactivation of SOX5.
    Chen D; Wang R; Yu C; Cao F; Zhang X; Yan F; Chen L; Zhu H; Yu Z; Feng J
    EBioMedicine; 2019 Jun; 44():150-161. PubMed ID: 31147293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sox5 contributes to prostate cancer metastasis and is a master regulator of TGF-β-induced epithelial mesenchymal transition through controlling Twist1 expression.
    Hu J; Tian J; Zhu S; Sun L; Yu J; Tian H; Dong Q; Luo Q; Jiang N; Niu Y; Shang Z
    Br J Cancer; 2018 Jan; 118(1):88-97. PubMed ID: 29123266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The T-box transcription factor Brachyury regulates epithelial-mesenchymal transition in association with cancer stem-like cells in adenoid cystic carcinoma cells.
    Shimoda M; Sugiura T; Imajyo I; Ishii K; Chigita S; Seki K; Kobayashi Y; Shirasuna K
    BMC Cancer; 2012 Aug; 12():377. PubMed ID: 22931165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TWIST1-mediated transcriptional activation of PDGFRβ in breast cancer stem cells promotes tumorigenesis and metastasis.
    Yeeravalli R; Kaushik K; Das A
    Biochim Biophys Acta Mol Basis Dis; 2021 Jul; 1867(7):166141. PubMed ID: 33845139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of brachyury contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma.
    Du R; Wu S; Lv X; Fang H; Wu S; Kang J
    J Exp Clin Cancer Res; 2014 Dec; 33(1):105. PubMed ID: 25499255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated expression of GNAS promotes breast cancer cell proliferation and migration via the PI3K/AKT/Snail1/E-cadherin axis.
    Jin X; Zhu L; Cui Z; Tang J; Xie M; Ren G
    Clin Transl Oncol; 2019 Sep; 21(9):1207-1219. PubMed ID: 30767161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SALL4 promotes tumor progression in breast cancer by targeting EMT.
    Chen T; Tsang JYS; Su XC; Li P; Sun WQ; Wong ILK; Choy KY; Yang Q; Tse GMK; Chan TH; Chow LMC
    Mol Carcinog; 2020 Oct; 59(10):1209-1226. PubMed ID: 32835442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous Production of IL1B by Breast Cancer Cells Drives Metastasis and Colonization of the Bone Microenvironment.
    Tulotta C; Lefley DV; Freeman K; Gregory WM; Hanby AM; Heath PR; Nutter F; Wilkinson JM; Spicer-Hadlington AR; Liu X; Bradbury SMJ; Hambley L; Cookson V; Allocca G; Kruithof de Julio M; Coleman RE; Brown JE; Holen I; Ottewell PD
    Clin Cancer Res; 2019 May; 25(9):2769-2782. PubMed ID: 30670488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-1204 targets VDR to promotes epithelial-mesenchymal transition and metastasis in breast cancer.
    Liu X; Bi L; Wang Q; Wen M; Li C; Ren Y; Jiao Q; Mao JH; Wang C; Wei G; Wang Y
    Oncogene; 2018 Jun; 37(25):3426-3439. PubMed ID: 29555976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfection of T-Box Transcription Factor
    Akimoto N; Nakamura K; Hijioka H; Kume K; Matsumura Y; Sugiura T
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30453543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential role of Brachyury in inducing epithelial-to-mesenchymal transition (EMT) and HIF-1α expression in breast cancer cells.
    Shao C; Zhang J; Fu J; Ling F
    Biochem Biophys Res Commun; 2015 Nov; 467(4):1083-9. PubMed ID: 26393908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRD7 suppresses invasion and metastasis in breast cancer by negatively regulating YB1-induced epithelial-mesenchymal transition.
    Niu W; Luo Y; Zhou Y; Li M; Wu C; Duan Y; Wang H; Fan S; Li Z; Xiong W; Li X; Li G; Ren C; Li H; Zhou M
    J Exp Clin Cancer Res; 2020 Feb; 39(1):30. PubMed ID: 32028981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-132, miR-15a and miR-16 synergistically inhibit pituitary tumor cell proliferation, invasion and migration by targeting Sox5.
    Renjie W; Haiqian L
    Cancer Lett; 2015 Jan; 356(2 Pt B):568-78. PubMed ID: 25305447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer cells obtain an osteomimetic feature via epithelial-mesenchymal transition that have undergone BMP2/RUNX2 signaling pathway induction.
    Tan CC; Li GX; Tan LD; Du X; Li XQ; He R; Wang QS; Feng YM
    Oncotarget; 2016 Nov; 7(48):79688-79705. PubMed ID: 27806311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of the EMT driver brachyury in breast carcinomas: association with poor prognosis.
    Palena C; Roselli M; Litzinger MT; Ferroni P; Costarelli L; Spila A; Cavaliere F; Huang B; Fernando RI; Hamilton DH; Jochems C; Tsang KY; Cheng Q; Lyerly HK; Schlom J; Guadagni F
    J Natl Cancer Inst; 2014 May; 106(5):. PubMed ID: 24815864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding Molecular Pathways and Targets of Brachyury in Epithelial-mesenchymal Transition (EMT) in Human Cancers.
    Song W; Gobe GC
    Curr Cancer Drug Targets; 2016; 16(7):586-93. PubMed ID: 27018266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WSZG inhibits BMSC-induced EMT and bone metastasis in breast cancer by regulating TGF-β1/Smads signaling.
    Ma J; Li J; Wang Y; Chen W; Zheng P; Chen Y; Sun Z; Liu J; Zhou Y; Wang J; Liu S; Han X
    Biomed Pharmacother; 2020 Jan; 121():109617. PubMed ID: 31810139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SMC1 promotes epithelial-mesenchymal transition in triple-negative breast cancer through upregulating Brachyury.
    Li K; Ying M; Feng D; Chen Y; Wang J; Wang Y
    Oncol Rep; 2016 Apr; 35(4):2405-12. PubMed ID: 26781859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.